v3.26.1
GOODWILL AND INTANGIBLE ASSETS
 9 Months Ended
Jul. 03, 2026
Intangible Asset, Goodwill and Other [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
    The following table reflects goodwill by reportable operating segment:
(In millions)MedicalIndustrialTotal
Balance at October 3, 2025$79.8 $118.6 $198.4 
Foreign currency translation adjustments(0.3)(0.5)(0.8)
Balance at July 3, 2026$79.5 $118.1 $197.6 
MedicalIndustrialTotal
Balance at July 3, 2026
Goodwill$173.4 $118.1 $291.5 
Accumulated impairment losses(93.9)— (93.9)
Total goodwill$79.5 $118.1 $197.6 
    The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in intangible assets, net in the Condensed Consolidated Balance Sheets:
July 3, 2026October 3, 2025
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Acquired existing technology
$73.9 $(66.4)$7.5 $74.9 $(65.5)$9.4 
Patents, licenses and other
7.6 (6.2)1.4 6.2 (6.2)— 
Customer contracts and supplier relationship
50.9 (47.4)3.5 52.3 (47.7)4.6 
Total intangible assets
$132.4 $(120.0)$12.4 $133.4 $(119.4)$14.0 
Amortization expense for intangible assets was $1.1 million and $1.0 million for the three months ended July 3, 2026 and July 4, 2025, respectively. Amortization expense for intangible assets was $3.3 million and $2.9 million for the nine months ended July 3, 2026 and July 4, 2025, respectively. During the nine months ended July 3, 2026, in connection with an asset acquisition, the Company recorded additional intangible assets of $1.8 million related to acquired licenses.